FDA Hits Snooze On Remanufacturing Draft Guidance, Cybersecurity Discussion Paper
Executive Summary
The US agency is extending public comment periods for a controversial draft guidance and a cybersecurity servicing paper that caution servicers that they could get in hot water for remanufacturing medical devices.